Application 209385
- Type
- ANDA
- Sponsor
- NOSTRUM LABS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OXYCODONE AND ACETAMINOPHEN | ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | TABLET;ORAL | 325MG;5MG | No | No |
| 002 | OXYCODONE AND ACETAMINOPHEN | ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | TABLET;ORAL | 325MG;7.5MG | No | No |
| 003 | OXYCODONE AND ACETAMINOPHEN | ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | TABLET;ORAL | 325MG;10MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209385-001 | OXYCODONE AND ACETAMINOPHEN | ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 325MG;5MG | TABLET / ORAL | AA | 2018-07-02 | |
| A209385-002 | OXYCODONE AND ACETAMINOPHEN | ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 325MG;7.5MG | TABLET / ORAL | AA | 2018-07-02 | |
| A209385-003 | OXYCODONE AND ACETAMINOPHEN | ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 325MG;10MG | TABLET / ORAL | AA | 2018-07-02 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209385-001 | AA |
| A209385-002 | AA |
| A209385-003 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A209385-001 | OXYCODONE AND ACETAMINOPHEN | 325MG;5MG | TABLET / ORAL | AA | 2018-07-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209385-002 | OXYCODONE AND ACETAMINOPHEN | 325MG;7.5MG | TABLET / ORAL | AA | 2018-07-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209385-003 | OXYCODONE AND ACETAMINOPHEN | 325MG;10MG | TABLET / ORAL | AA | 2018-07-02 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209385-001 | OXYCODONE AND ACETAMINOPHEN | 325MG;5MG | TABLET / ORAL | AA | 2018-07-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209385-002 | OXYCODONE AND ACETAMINOPHEN | 325MG;7.5MG | TABLET / ORAL | AA | 2018-07-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209385-003 | OXYCODONE AND ACETAMINOPHEN | 325MG;10MG | TABLET / ORAL | AA | 2018-07-02 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209385-001 | OXYCODONE AND ACETAMINOPHEN | 325MG;5MG | TABLET / ORAL | AA | 2018-07-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209385-002 | OXYCODONE AND ACETAMINOPHEN | 325MG;7.5MG | TABLET / ORAL | AA | 2018-07-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209385-003 | OXYCODONE AND ACETAMINOPHEN | 325MG;10MG | TABLET / ORAL | AA | 2018-07-02 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209385-001 | OXYCODONE AND ACETAMINOPHEN | 325MG;5MG | TABLET / ORAL | AA | 2018-07-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209385-002 | OXYCODONE AND ACETAMINOPHEN | 325MG;7.5MG | TABLET / ORAL | AA | 2018-07-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209385-003 | OXYCODONE AND ACETAMINOPHEN | 325MG;10MG | TABLET / ORAL | AA | 2018-07-02 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209385-001 | OXYCODONE AND ACETAMINOPHEN | 325MG;5MG | TABLET / ORAL | AA | 2018-07-02 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209385-002 | OXYCODONE AND ACETAMINOPHEN | 325MG;7.5MG | TABLET / ORAL | AA | 2018-07-02 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209385-003 | OXYCODONE AND ACETAMINOPHEN | 325MG;10MG | TABLET / ORAL | AA | 2018-07-02 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209385-001 | OXYCODONE AND ACETAMINOPHEN | 325MG;5MG | TABLET / ORAL | AA | 2018-07-02 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209385-002 | OXYCODONE AND ACETAMINOPHEN | 325MG;7.5MG | TABLET / ORAL | AA | 2018-07-02 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209385-003 | OXYCODONE AND ACETAMINOPHEN | 325MG;10MG | TABLET / ORAL | AA | 2018-07-02 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209385-001 | OXYCODONE AND ACETAMINOPHEN | 325MG;5MG | TABLET / ORAL | AA | 2018-07-02 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209385-002 | OXYCODONE AND ACETAMINOPHEN | 325MG;7.5MG | TABLET / ORAL | AA | 2018-07-02 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209385-003 | OXYCODONE AND ACETAMINOPHEN | 325MG;10MG | TABLET / ORAL | AA | 2018-07-02 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209385-001 | OXYCODONE AND ACETAMINOPHEN | 325MG;5MG | TABLET / ORAL | AA | 2018-07-02 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209385-002 | OXYCODONE AND ACETAMINOPHEN | 325MG;7.5MG | TABLET / ORAL | AA | 2018-07-02 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209385-003 | OXYCODONE AND ACETAMINOPHEN | 325MG;10MG | TABLET / ORAL | AA | 2018-07-02 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209385-001 | OXYCODONE AND ACETAMINOPHEN | 325MG;5MG | TABLET / ORAL | AA | 2018-07-02 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209385-002 | OXYCODONE AND ACETAMINOPHEN | 325MG;7.5MG | TABLET / ORAL | AA | 2018-07-02 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209385-003 | OXYCODONE AND ACETAMINOPHEN | 325MG;10MG | TABLET / ORAL | AA | 2018-07-02 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209385-001 | OXYCODONE AND ACETAMINOPHEN | 325MG;5MG | TABLET / ORAL | AA | 2018-07-02 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209385-002 | OXYCODONE AND ACETAMINOPHEN | 325MG;7.5MG | TABLET / ORAL | AA | 2018-07-02 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209385-003 | OXYCODONE AND ACETAMINOPHEN | 325MG;10MG | TABLET / ORAL | AA | 2018-07-02 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209385-001 | OXYCODONE AND ACETAMINOPHEN | 325MG;5MG | TABLET / ORAL | AA | 2018-07-02 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209385-002 | OXYCODONE AND ACETAMINOPHEN | 325MG;7.5MG | TABLET / ORAL | AA | 2018-07-02 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209385-003 | OXYCODONE AND ACETAMINOPHEN | 325MG;10MG | TABLET / ORAL | AA | 2018-07-02 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209385-001 | OXYCODONE AND ACETAMINOPHEN | 325MG;5MG | TABLET / ORAL | 2018-07-02 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209385-002 | OXYCODONE AND ACETAMINOPHEN | 325MG;7.5MG | TABLET / ORAL | 2018-07-02 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209385-003 | OXYCODONE AND ACETAMINOPHEN | 325MG;10MG | TABLET / ORAL | 2018-07-02 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209385-001 | OXYCODONE AND ACETAMINOPHEN | 325MG;5MG | TABLET / ORAL | 2018-07-02 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209385-002 | OXYCODONE AND ACETAMINOPHEN | 325MG;7.5MG | TABLET / ORAL | 2018-07-02 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209385-003 | OXYCODONE AND ACETAMINOPHEN | 325MG;10MG | TABLET / ORAL | 2018-07-02 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209385-001 | OXYCODONE AND ACETAMINOPHEN | 325MG;5MG | TABLET / ORAL | 2018-07-02 | 1e350fbaab3a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A209385-001 | AA | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209385-002 | AA | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209385-003 | AA | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A209385-001 | AA | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209385-002 | AA | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209385-003 | AA | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209385-001 | AA | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209385-002 | AA | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209385-003 | AA | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A209385-001 | AA | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209385-002 | AA | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209385-003 | AA | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209385-001 | AA | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209385-002 | AA | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209385-003 | AA | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209385-001 | AA | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209385-002 | AA | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209385-003 | AA | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209385-001 | AA | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209385-002 | AA | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209385-003 | AA | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209385-001 | AA | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209385-002 | AA | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209385-003 | AA | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209385-001 | AA | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209385-002 | AA | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209385-003 | AA | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209385-001 | AA | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209385-002 | AA | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209385-003 | AA | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A209385-001 | AA | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A209385-002 | AA | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A209385-003 | AA | 1 | d06236e962d9… |
| 2019-12-13 00:20 UTC | 2019-12 | A209385-001 | AA | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A209385-002 | AA | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A209385-003 | AA | 1 | 74a2ff9319b5… |
| 2020-11-12 02:37 UTC | 2020-11 | A209385-001 | AA | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A209385-002 | AA | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A209385-003 | AA | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A209385-001 | AA | 1 | 3f01610625f2… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxycodone Hydrochloride and Acetaminophen | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | St. Mary's Medical Park Pharmacy | 40a68a27-4422-5ba0-e063-6294a90ac550 | 2026-08-14 | Boxed warning, Warnings, Adverse reactions | 209385 ANDA209385 |
| Oxycodone Hydrochloride and Acetaminophen | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | St. Mary's Medical Park Pharmacy | 40a882d6-a4db-1ad9-e063-6394a90a7268 | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | 209385 ANDA209385 |
| Oxycodone Hydrochloride and Acetaminophen | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | St. Mary's Medical Park Pharmacy | 53de17b1-6d5b-c7c0-e063-6394a90a7064 | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | 209385 ANDA209385 |
| Oxycodone Hydrochloride and Acetaminophen | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | Elite Laboratories, Inc. | 27fa8190-d334-4bb9-b277-d1f44db433e3 | 2026-04-09 | Boxed warning, Warnings, Adverse reactions | 209385 ANDA209385 64850-622 64850-621 64850-623 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 64850-621 | Oxycodone Hydrochloride and Acetaminophen | Oxycodone Hydrochloride and Acetaminophen | Elite Laboratories, Inc. | ANDA | Current |
| 64850-621 | Oxycodone Hydrochloride and Acetaminophen | Oxycodone Hydrochloride and Acetaminophen | Elite Laboratories, Inc. | ANDA | Current |
| 64850-621 | Oxycodone Hydrochloride and Acetaminophen | Oxycodone Hydrochloride and Acetaminophen | Elite Laboratories, Inc. | ANDA | Current |
| 64850-621 | Oxycodone Hydrochloride and Acetaminophen | Oxycodone Hydrochloride and Acetaminophen | Elite Laboratories, Inc. | ANDA | Current |
| 64850-621 | Oxycodone Hydrochloride and Acetaminophen | Oxycodone Hydrochloride and Acetaminophen | Elite Laboratories, Inc. | ANDA | Current |
| 64850-622 | Oxycodone Hydrochloride and Acetaminophen | Oxycodone Hydrochloride and Acetaminophen | Elite Laboratories, Inc. | ANDA | Current |
| 64850-622 | Oxycodone Hydrochloride and Acetaminophen | Oxycodone Hydrochloride and Acetaminophen | Elite Laboratories, Inc. | ANDA | Current |
| 64850-622 | Oxycodone Hydrochloride and Acetaminophen | Oxycodone Hydrochloride and Acetaminophen | Elite Laboratories, Inc. | ANDA | Current |
| 64850-622 | Oxycodone Hydrochloride and Acetaminophen | Oxycodone Hydrochloride and Acetaminophen | Elite Laboratories, Inc. | ANDA | Current |
| 64850-622 | Oxycodone Hydrochloride and Acetaminophen | Oxycodone Hydrochloride and Acetaminophen | Elite Laboratories, Inc. | ANDA | Current |
| 64850-623 | Oxycodone Hydrochloride and Acetaminophen | Oxycodone Hydrochloride and Acetaminophen | Elite Laboratories, Inc. | ANDA | Current |
| 64850-623 | Oxycodone Hydrochloride and Acetaminophen | Oxycodone Hydrochloride and Acetaminophen | Elite Laboratories, Inc. | ANDA | Current |
| 64850-623 | Oxycodone Hydrochloride and Acetaminophen | Oxycodone Hydrochloride and Acetaminophen | Elite Laboratories, Inc. | ANDA | Current |
| 64850-623 | Oxycodone Hydrochloride and Acetaminophen | Oxycodone Hydrochloride and Acetaminophen | Elite Laboratories, Inc. | ANDA | Current |
| 64850-623 | Oxycodone Hydrochloride and Acetaminophen | Oxycodone Hydrochloride and Acetaminophen | Elite Laboratories, Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 76217 | ORIG | 2023-11-03 |